-
DRUG SHORTAGES FINAL RULE RETROSPECTIVE ANALYSIS
Mar 18, 2026, 21:38 PM -
REAL-WORLD SAFETY TRENDS OF GLP-1 RECEPTOR AGONISTS IN THE UNITED STATES: ANALYSIS OF FAERS REPORTS (2015-2025)
Mar 18, 2026, 21:38 PM -
VALIDATION OF A NEW CLINICAL OUTCOME ASSESSMENT: THE VACCINATION EXPERIENCE QUESTIONNAIRE (VEQ)
Mar 18, 2026, 21:38 PM -
COMPARATIVE MEASUREMENT OF ESKETAMINE RESPONSE IN TREATMENT-RESISTANT DEPRESSION USING PHQ-9 AND DSM-5 CRITERIA
Mar 18, 2026, 21:38 PM -
HEALTH OUTCOMES AND IMPLEMENTATION EFFECTIVENESS OF THE ANKYLOSING SPONDYLITIS RURAL HEALTH PROJECT IN CHINA: A PROSPECTIVE COHORT STUDY FROM HEALTH EQUITY PERSPECTIVE
Mar 18, 2026, 21:38 PM -
EXPANDING ACCESS TO LONG-ACTING REVERSIBLE CONTRACEPTIVES: A STATE-LEVEL BUDGET IMPACT MODEL OF SOUTH CAROLINA
Mar 18, 2026, 21:38 PM -
ONE BIG BEAUTIFUL ACT (OBBA) MEDICAID FUNDING CHANGES IMPACT ON MEDICAID VOLUMES IN CLAIMS DATA; A STUDY OF IMPACT FROM REENROLLMENT REQUIREMENTS OF 2024
Mar 18, 2026, 21:38 PM -
THE FUTURE OF EVIDENCE SYNTHESIS AND GENERATION IN HEOR: A SECURE FRAMEWORK FOR DOMAIN SPECIFIC ADAPTATION AND FINE-TUNING OF LARGE LANGUAGE MODELS
Mar 18, 2026, 21:38 PM -
EVOLUTION OF HOMOLOGOUS RECOMBINATION REPAIR (HRR) GENETIC TESTING BY RACE AMONG PATIENTS WITH METASTATIC PROSTATE CANCER (MPC) IN A LARGE COMMUNITY ONCOLOGY SETTING IN THE US, 2015-2024
Mar 18, 2026, 21:38 PM -
ASSOCIATION BETWEEN PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL AMONG INDIVIDUALS RECEIVING FIRST-LINE TREATMENT FOR BRCA WILD-TYPE ADVANCED EPITHELIAL OVARIAN CANCER: A PATIENT-LEVEL ANALYSIS OF POOLED HISTORICAL CLINICAL TRIALS
Mar 18, 2026, 21:38 PM -
REAL-WORLD TREATMENT PATTERNS AND TREATMENT INTENSIFICATION IN METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) BY DISEASE VOLUME AND PRESENTATION
Mar 18, 2026, 21:38 PM -
COST OF AMPUTATION FOLLOWING LOWER EXTREMITY ENDOVASCULAR REVASCULARIZATION IN PERIPHERAL ARTERY DISEASE
Mar 18, 2026, 21:38 PM -
ACCESS TO ESSENTIAL BREAST AND CERVICAL CANCER MEDICINES IN NIGERIA: A WHO/HAI-BASED EVALUATION OF PRICES, AVAILABILITY, AND AFFORDABILITY
Mar 18, 2026, 21:38 PM -
APPLYING THE POMELO BEST PRACTICES FRAMEWORK TO ENHANCE REPORTING STANDARDS IN PATIENT LISTENING STUDIES FROM SOCIAL MEDIA
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF LATENT TUBERCULOSIS INFECTION INTERVENTIONS IMPLEMENTED DURING THE TUBERCULOSIS EPIDEMIOLOGIC STUDIES CONSORTIUM (TBESC-III)
Mar 18, 2026, 21:38 PM -
TREATMENT PATTERN IN PATIENTS WITH ADVANCED BREAST CANCER AFTER CDK4/6I FAILURE IN CHINA
Mar 18, 2026, 21:38 PM -
ECONOMIC EVALUATION OF TARGETED PERINATAL DEPRESSION SCREENING FOR HIGH-RISK WOMEN IN CHINA
Mar 18, 2026, 21:38 PM -
FACTORS ASSOCIATED WITH TREATMENT ENGAGEMENT AMONG EMERGENCY DEPARTMENT PATIENTS WITH OPIOID USE DISORDER AFTER DISCHARGE: A RETROSPECTIVE COHORT STUDY
Mar 18, 2026, 21:38 PM -
INDIRECT TREATMENT COMPARISONS IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: INSIGHTS FROM RECENT NICE SUBMISSIONS
Mar 18, 2026, 21:38 PM -
REAL-WORLD USE OF BIOLOGICS IN CROHN’S DISEASE: ALIGNMENT WITH HEALTH PLAN COVERAGE REQUIREMENTS
Mar 18, 2026, 21:38 PM
